1. Investment Snapshot
2. Thesis
3. Valuation & Price Target
4. Business & Product Moat
5. People & Governance
6. Market & Macro
7. Financial Quality
8. Risk Register
9. Prediction Market
10. 𝕏 Posts
Discussion
1. Investment Snapshot
2. Thesis
3. Valuation & Price Target
4. Business & Product Moat
5. People & Governance
6. Market & Macro
7. Financial Quality
8. Risk Register
9. Prediction Market
10. 𝕏 Posts
Discussion
1. Investment Snapshot
2. Valuation
Discussion
Symbol
STSS
Event Date
2022-04-13
Sector
Health Care
Subsector
Health Care Equipment & Supplies
Offer Range
$4.25
Shares Offered
3.75M
9.17M
$39.0M
40.9%
Implied Upside vs Midpoint
Description
Sharps Technology, Inc. is a medical device company that has designed and patented various safety syringes which we are seeking to commercialize. Our safety syringes products, which we refer to as the Sharps Provensa™, are ultra-low waste and have passive safety features, which we believe will provide us a competitive advantage over other syringes. Sharps Provensa is a patented and FDA-cleared safety syringe addressing the important needs of the global healthcare market. We received FDA clearance for the Sharps Provensa on June 12, 2006, for subcutaneous and intramuscular injections into the human body. As further discussed below, although we currently have some production capacity and thus ability to receive and fulfill orders, we expect that completing this offering will allow us to increase our production capacity and thus help us to generate and fulfill orders for our Sharps Provensa product line. We anticipate that we will commence receiving orders for and producing commercial quantities of our Sharps Provensa upon and subject to successful completion of this offering. However, we have not generated sales or received any orders to date and there is no assurance we will receive any orders for our products. --- The Company was incorporated in the State of Wyoming on December 16, 2017. On March 22, 2022, we reincorporated as a Nevada corporation. Our principal business address is 105 Maxess Road, Melville, New York 11747. We maintain our corporate website at www.sharpstechnology.com.
Sharps Technology Inc. annual income statement and balance sheet, FY 2022 to FY 2025, as reported in SEC filings.
| Metric | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|
| Revenue | — | — | — | $204K |
| Gross profit | — | — | — | ($413K) |
| Operating income | ($8.7M) | ($10.1M) | ($5.6M) | ($270M) |
| Net income | ($4.6M) | ($9.8M) | ($9.3M) | ($283M) |
| Metric | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|
| Total assets | $11.8M | $11.8M | $7.3M | $269M |
| Total liabilities | $2.2M | $3.9M | $5.3M | $4.7M |
| Total equity | $9.6M | $7.9M | $2.0M | $264M |
| Cash & equivalents | $4.2M | $3.0M | $755K | $10.4M |